Singapore-based Basel Medical Group, listed on Nasdaq, is actively in negotiations to acquire $1 billion worth of Bitcoin. This move aligns with the company's strategy to enhance its presence and growth trajectory within the Asian market.

The acquisition of Bitcoin marks a significant endeavor for Basel Medical Group as it seeks to integrate cryptocurrencies into its financial operations, leveraging the potential benefits of digital assets to achieve their strategic goals.